Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by NOIRISH on Feb 27, 2017 5:58pm

$IBB

If you want healthcare exposure, switch to $IBB a pharma index fund.

$CXRX  got kicked out of the index in December, 2016 due to its market capitalization.  Lower your risk even if there is only a remote chance of bankruptcy here - Trump isn't going to be kind to a Canadian owned pharma company ..
Comment by rad10 on Feb 27, 2017 7:55pm
IBB is a good bet - but I have tried to scoop up "fallen angels" into a mini index.  BMY and Allergan have had significant pullbacks to compelling valuations.  I personally like Allergan, Novo Nordisk, BMY, Pfizer and JnJ.
Comment by BlueJaysFan on Feb 27, 2017 8:03pm
rad,  I like JnJ....   They have so MANY PRODUCTS and you don't have to watch it every day ... Who the heck is MrHulot who seems to be having a very very bad day and has this wierd kink going on for coachroaches ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities